Portfolio company
Affinivax
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vaxdyn
Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.
Centivax
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
Dynavax Technologies
This biopharmaceutical company develops and commercialises novel vaccines and adjuvants for healthcare providers to protect adults against infectious diseases like hepatitis B.
Astrivax
This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.
GlycoVaxyn
This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
Revealis Biotherapeutics
This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
